Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Mar;1(2):89-92.
doi: 10.1023/A:1016307515811.

Proton magnetic resonance studies of the decomposition of 4-hydroxycyclophosphamide, a microsomal metabolite of cyclophosphamide

Affiliations
Free article

Proton magnetic resonance studies of the decomposition of 4-hydroxycyclophosphamide, a microsomal metabolite of cyclophosphamide

E J Valente et al. Pharm Res. 1984 Mar.
Free article

Abstract

The proposed tautomeric equilibrium between the microsomal metabolite of cyclophosphamide, 4-hydroxycyclophosphamide, and the open chain aldophosphamide, and the subsequent facile β-elimination to generate acrolein and phosphoramide mustard have been confirmed by proton magnetic resonance studies. When 4-hydroxycyclophosphamide, initially maintained in CDC13 at -20°C, was allowed to equilibrate at 15°C, a singlet at 9.76 δ and a triplet at 2.88 δ appeared concomitantly which were assigned to the aldehydic proton and the protons α to the carbonyl of aldophosphamide, respectively. Further reaction led to the appearance of several NMR signals that indicated the irreversible formation of acrolein (multiplet at 9.55 δ) and phosphoramide mustard. Polymerization occurred approximately 2 hours after the initiation of the reaction. The kinetic data of the reaction sequence are discussed.

PubMed Disclaimer

Similar articles

References

    1. Cancer Res. 1976 Mar;36(3):1121-6 - PubMed
    1. Cancer Res. 1961 Jan;21:57-63 - PubMed
    1. Arzneimittelforschung. 1963 Dec;13:1021-31 - PubMed
    1. Cancer Res. 1974 Nov;34(11):2933-5 - PubMed
    1. Arzneimittelforschung. 1974 Aug;24(8):1172-6 - PubMed